{"nct_id":"NCT04031885","title":"A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer","status":"TERMINATED","status_verified_date":"2021-07","start_date":"2019-08-14","start_date_type":"ACTUAL","primary_completion_date":"2020-08-11","primary_completion_date_type":"ACTUAL","completion_date":"2020-08-11","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["LLY"]}